WallStreetZenWallStreetZen

NASDAQ: MEDS
Datameds Ai Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their MEDS stock forecasts and price targets.

Forecast return on equity

Is MEDS forecast to generate an efficient return?

Company
-1.92%
Industry
10.29%
Market
149.89%
MEDS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MEDS forecast to generate an efficient return on assets?

Company
1.14%
Industry
5.23%
MEDS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MEDS earnings per share forecast

What is MEDS's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.73
Avg 2 year Forecast
-$0.21
Avg 3 year Forecast
$0.23

MEDS revenue forecast

What is MEDS's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$5.2M-34.87%
Avg 2 year Forecast
$17.6M+118.88%
Avg 3 year Forecast
$38.7M+382.86%
MEDS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MEDS revenue growth forecast

How is MEDS forecast to perform vs Pharmaceutical Retailers companies and vs the US market?

Company
59.88%
Industry
107.3%
Market
14.66%
MEDS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MEDS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MEDS vs Pharmaceutical Retailer Stocks

TickerPricePrice TargetUp/downsideConsensus
MEDS$0.89N/AN/A
HKPD$0.12N/AN/A
RDGT$0.84N/AN/A
POM$0.74N/AN/A
SCNX$0.36N/AN/A
View Top Pharmaceutical Retailer Stocks

Datameds Ai Stock Forecast FAQ

What is MEDS's earnings growth forecast for 2026-2028?

(NASDAQ: MEDS) Datameds Ai's forecast annual earnings growth rate of N/A is not forecast to beat the US Pharmaceutical Retailers industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of 62.91%.

Datameds Ai's earnings in 2026 is -$88,276,985.On average, 3 Wall Street analysts forecast MEDS's earnings for 2026 to be -$1,173,319, with the lowest MEDS earnings forecast at -$1,127,306, and the highest MEDS earnings forecast at -$1,207,828. On average, 3 Wall Street analysts forecast MEDS's earnings for 2027 to be -$342,218, with the lowest MEDS earnings forecast at -$328,798, and the highest MEDS earnings forecast at -$352,283.

In 2028, MEDS is forecast to generate $374,810 in earnings, with the lowest earnings forecast at $360,112 and the highest earnings forecast at $385,834.

If you're new to stock investing, here's how to buy Datameds Ai stock.

What is MEDS's revenue growth forecast for 2026-2028?

(NASDAQ: MEDS) Datameds Ai's forecast annual revenue growth rate of 59.88% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 107.3%, and while it is forecast to beat the US market's average forecast revenue growth rate of 14.66%.

Datameds Ai's revenue in 2026 is $8,022,975.On average, 3 Wall Street analysts forecast MEDS's revenue for 2026 to be $8,347,753, with the lowest MEDS revenue forecast at $8,021,831, and the highest MEDS revenue forecast at $8,593,792. On average, 3 Wall Street analysts forecast MEDS's revenue for 2027 to be $28,056,437, with the lowest MEDS revenue forecast at $26,957,250, and the highest MEDS revenue forecast at $28,882,425.

In 2028, MEDS is forecast to generate $61,893,193 in revenue, with the lowest revenue forecast at $59,464,756 and the highest revenue forecast at $63,712,924.

What is MEDS's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: MEDS) forecast ROA is 1.14%, which is lower than the forecast US Pharmaceutical Retailers industry average of 5.23%.

What is MEDS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MEDS) Datameds Ai's current Earnings Per Share (EPS) is -$46.63. On average, analysts forecast that MEDS's EPS will be -$0.73 for 2026, with the lowest EPS forecast at -$0.71, and the highest EPS forecast at -$0.76. On average, analysts forecast that MEDS's EPS will be -$0.21 for 2027, with the lowest EPS forecast at -$0.21, and the highest EPS forecast at -$0.22. In 2028, MEDS's EPS is forecast to hit $0.23 (min: $0.23, max: $0.24).

What is MEDS's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: MEDS) forecast ROE is -1.92%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.